Author

Thomas K. Nordt

Observed names: T Nordt, Thomas K Nordt, Thomas Nordt, Thomas Nordt MD

Institutions: Katharinenhospital, Klinikum Stuttgart

Observed institutions: University of Vermont, University of Helsinki, University of Freiburg, Washington University in St. Louis, Heidelberg University, University Medical Center Freiburg, University of Vermont Medical Center, University Hospital Heidelberg, Katharinenhospital, Klinikum Stuttgart, Duke Clinical Research Institute

OpenAlex ID: A5110168744

Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodulin

1997 · Karlheinz Peter, Peter Nawroth, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 306

Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors

1998 · Karlheinz Peter, Meike Schwarz, et al. · Blood · 227

Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes: A Potential Pathogenetic Link Between Obesity and Cardiovascular Disease

1996 · Craig H. Lundgren, Steven L. Brown, et al. · Circulation · 225

Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo

1995 · Thomas K. Nordt, Hirofumi Sawa, et al. · Circulation · 186

Attenuated Fibrinolysis and Accelerated Atherogenesis in Type II Diabetic Patients

1993 · David J Schneider, Thomas K Nordt, et al. · Diabetes · 178

Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18)

1999 · Karlheinz Peter, Meike Schwarz, et al. · Circulation · 126

Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells

1992 · David J Schneider, Thomas K Nordt, et al. · Diabetes · 123

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2)

2002 · Meike Schwarz, Thomas Nordt, et al. · Thrombosis Research · 83

Platelet Function During and After Thrombolytic Therapy for Acute Myocardial Infarction With Reteplase, Alteplase, or Streptokinase

1999 · Martin Moser, Thomas Nordt, et al. · Circulation · 71

Oxidative Stress and Atherosclerosis: Its Relationship to Growth Factors, Thrombus Formation and Therapeutic Approaches

1999 · Karlheinz Peter, Wolfgang Kübler, et al. · Thrombosis and Haemostasis · 65

Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones

2004 · Anne Leugers, Jens Lohrmann, et al. · Thrombosis and Haemostasis · 57

Flow Cytometric Monitoring of Glycoprotein IIb/IIIa Blockade and Platelet Function in Patients With Acute Myocardial Infarction Receiving Reteplase, Abciximab, and Ticlopidine

2000 · Karlheinz Peter, Benedikt Kohler, et al. · Circulation · 54

Regulation of PAI-1 Expression by Genetic Polymorphisms

2001 · Thomas K Nordt, Jens Lohrmann, et al. · Thrombosis Research · 51

Augmentation of Arterial Endothelial Cell Expression of the Plasminogen Activator Inhibitor Type-1 (PAI-1) Gene by Proinsulin and Insulinin vivo

1998 · T Nordt, H Sawa, et al. · Journal of Molecular and Cellular Cardiology · 50

Differential Regulation by Troglitazone of Plasminogen Activator Inhibitor Type 1 in Human Hepatic and Vascular Cells

2000 · Thomas K. Nordt, Karlheinz Peter, et al. · The Journal of Clinical Endocrinology & Metabolism · 44

Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction

1991 · Eberhard von Hodenberg, Jörg Kreuzer, et al. · The American Journal of Cardiology · 38

Adhesion of Monocytes to Medical Steel as Used for Vascular Stents is Mediated by the Integrin Receptor Mac-1 (CD11b/CD18; α M β 2 ) and Can be Inhibited by Semiconductor Coating

2003 · Pia Schuler, Dawit Assefa, et al. · Cell Communication & Adhesion · 35

PDF

Intrinsic Activating Properties of GP IIb/IIIa Blockers

2001 · Karlheinz Peter, Meike Schwarz, et al. · Thrombosis Research · 33

Impaired Endogenous Fibrinolysis in Diabetes Mellitus: Mechanisms and Therapeutic Approaches

2000 · Thomas K. Nordt, Christoph Bode · Seminars in Thrombosis and Hemostasis · 31

Attenuation by Gemfibrozil of Expression of Plasminogen Activator Inhibitor Type 1 Induced by Insulin and its Precursors

1997 · Thomas K. Nordt, Katharina Kornas, et al. · Circulation · 24

Ecarin Clotting Time but not aPTT Correlates with PEG-Hirudin Plasma Activity

2001 · Martin Moser MD, Johannes Ruef MD, et al. · Journal of Thrombosis and Thrombolysis · 22

Effects of Different Thrombolytic Treatment Regimen with Abciximab and Tirofiban on Platelet Aggregation and Platelet-Leukocyte Interactions: A Subgroup Analysis from the GUSTO V and FASTER Trials

2002 · Ulf Bertram, Martin Moser, et al. · Journal of Thrombosis and Thrombolysis · 17

Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin

1993 · Kevin J. Klassen, Thomas K. Nordt, et al. · Coronary Artery Disease · 17

Cobalt–chrome MULTI-LINK VISION™-stent implantation in diabetics and complex lesions: results from the DaVinci-Registry

2009 · Holger M. Nef, Helge Möllmann, et al. · Clinical Research in Cardiology · 14

Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes

2009 · Sandra Ernst, Anne Leugers, et al. · Thrombosis and Haemostasis · 14

Works count: 44

Citation count: 2,148

H-index: 21

I10-index: 28